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a  b  s  t  r  a  c  t
Treatment  with  DAPT,  an  inhibitor  of  the  Notch-activating  enzyme,  -secretase  is known  to  reduce  dam-
age  to  ischemic  brain.  However,  the  molecular  mechanisms  supporting  this  therapeutic  effect  are  not  fully
understood.  Here  we demonstrated  that  Notch/RBP-J  signaling  is  activated  in NG2+ glial  progenitors  and
reactive  astrocytes  such  as  GFAP+ cells,  Nestin+ cells  and RC2+ cells,  using  Notch/RBP-J  signaling  reporter
+eywords:
otch
BP-J
schemia, Reactive astrocytes
mice.  3-day  DAPT  treatment  reduced  the  number  of  reactive  astrocytes  but  not  NG2 glial  progenitors.
BrdU  labeling  experiments  have  shown  that  this  reduction  was  due  to decreased  proliferation  of  reac-
tive  astrocytes.  DAPT  inhibited  nuclear-translocation  of  Olig2,  which  is  indispensable  for proliferation
and  differentiation  of  reactive  astrocytes.  These  ﬁndings  suggest  that  Notch  signaling  might  promote
proliferation  and  differentiation  of  reactive  astrocytes  through  the regulation  of nucleo-cytoplasmic
eland  
lig2 translocation  of Olig2.
© 2013 Elsevier Ir   
. Introduction
Notch/RBP-J signaling has been known to regulate various
spects of neural cell fate speciﬁcation (Androutsellis-Theotokis
t  al., 2006; de la Pompa et al., 1997; Fujimoto et al., 2009; Ohtsuka
t al., 2001). Notch is a cell-surface receptor. Ligand binding to
otch leads to its proteolytic clevages. The released intracellular
omain translocates to the nucleus and upregulates the tran-
cription of its target genes by interacting with a DNA-binding
rotein, RBP-J (Kato et al., 1997; Tamura et al., 1995). This cleav-
ge is accomplished by the -secretase complex (Selkoe and Kopan,
003).
Reactive astrogliosis is a crucial response to brain injuries such
s trauma, infection and ischemia. Reactive astrocytes generate
rom proliferating cells (Alonso, 2005). Pulse-chase labeling exper-
ments with 5-bromo-2′-deoxyuridine (BrdU) suggested that NG2
ells might be a source of reactive astrocytes. However, genetic
ate mapping analysis suggested that most of reactive astrocytes
ifferentiate from quiescent astrocytes, which resumes prolifera-
ion upon brain injury but not from NG2 cells (Buffo et al., 2008;
omitova et al., 2011).
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In culture of neural stem cells and glial progenitors, Olig2
inhibits astrocytic differentiation (Fukuda et al., 2004) and
nucleo-cytoplasmic Olig2 translocation mediates differentiation
of astrocytes (Magnus et al., 2007; Setoguchi and Kondo, 2004).
The translocation of Olig2 is also observed in brain-injury-
induced reactive astrogliogenesis in vivo (Magnus et al., 2007),
but astrocyte-speciﬁc conditional knockout studies have shown
that Olig2 is indispensable for reactive astrocyte proliferation
rather than inhibits their differentiation (Chen et al., 2008). Notch
signaling promotes astrocytic differentiation (Ge et al., 2002;
Tanigaki et al., 2001) and Olig2 is a direct target of Notch signaling
(Fujimoto et al., 2009). Notch inhibition by a -secretase inhibitor
(GSI) decreases proliferation of reactive astrocytes after brain injury
(Shimada et al., 2011).
Here  we  examined the effects of Notch signaling on subpopu-
lations of proliferating glial cells and localization of Olig2 in vivo
after ischemic stroke. Our experiments have shown differential
roles of Notch signaling in glial populations after ischemic stroke.
Notch signaling upregulates Olig2 expression and promotes
Olig2 localization in nucleus in GFAP-positive cells in reactive
astrogliogenesis in vivo.
2.  Methods
Open access under CC BY-NC-ND license.2.1. Transient focal cerebral ischemia
Cerebral ischemia was  induced by using the intraluminal middle
cerebral artery occlusion (MCAO) method as described previously
r CC BY-NC-ND license. 
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Longa et al., 1989). Anesthesia was maintained using a mixture
ontaining 1% halothane in 30% oxygen and 70% nitrous oxide.
ectal temperature was maintained at 37 C◦ with a thermostat-
ontrolled heating pad. After 60 min  MCAO with a 8.0 nylon
onoﬁlament coated with silicon, the ﬁlament was withdrawn.
egional cerebral blood ﬂows of the mice were measured with a
aser–Doppler ﬂowmetry (Omegawave, Tokyo, Japan) to conﬁrm
he induction of ischemia and reperfusion. After MCAO, the mice
ere placed in a thermally controlled incubator (32 ◦C) for 2 h.
-Secretase inhibitor, 100 mg/kg N-S-phenyl-glycine-t-butyl ester
DAPT) (Tocris, Bristol, UK) or dimethylsulfoxide (DMSO) (control)
as injected subcateneously (s.c.) 3 h before MCAO and every 12 h
fter MCAO. DAPT was dissolved in DMSO (250 mg/ml) and diluted
nto a mixture of 5% EtOH and 95% corn oil to the ﬁnal volume of
0 mL/kg.
.2.  BrdU labeling analysisMice  were sacriﬁced 3 days after MCAO. They were intraperi-
oneally with BrdU (100 mg/kg) once 2 h before sacriﬁce. Mice
ere then perfused transcardially with 4% paraformaldehyde in
ig. 1. Reporter gene expression in the Notch signaling reporter transgenic mice.
A) Schematic representation of a Notch signaling reporter gene. Promoter containing 4×
eporter gene is ﬂanked by mouse H19 insulator elements.
B  and C) Reporter gene expression was observed in the subventricular zone of adult mi
hown in lower panels (B). Venus expression was upregulated in the subventricular zone
anels).search 75 (2013) 204–209 205
PBS.  Brains were ﬁxed for 12 h in 4% PFA, then transferred to a
30% sucrose and were embedded in tissue-tek O. C. T. compound
(Sakura Finetechnical, Tokyo, Japan) and cut at 40 m thickness.
BrdU staining was performed as described previously (Handler
et al., 2000).
2.3.  Immunohistochemistry of tissue sections
Mice were perfused and sectioned, as above. Immunohisto-
chemical staining was performed with primary antibodies for 24 h
at 4 ◦C after blocking for 1 h at room temperature with 5% donkey
serum (Millipore, Billerica, USA). Then the sections were incubated
for 1 h at room temperature with secondary antibodies (Molecular
Probes, Eugene, USA). The primary antibodies used were anti-BrdU
(BU1/75, Oxford Biotechnology, Oxfordshire, UK), anti-PSA-NCAM
(Millipore), anti-Dlx2 (Millipore), anti-GFAP (DAKO, Glostrup,
Denmark, BD Biosciences Immunocytometry Systems, San Jose,
CA, USA), anti-Olig2 (IBL, Gunma, Japan), anti-Nestin (Millipore,
BD Biosciences Immunocytometry Systems), anti-RC-2 (Millipore),
anti-NG2 (Millipore), anti-active Caspase3 (Promega, Madison,
WI, USA), anti-Hes1 (Abcam, Cambridge, MA, USA) antibodies.
 RBP-J-binding motifs and a SV40 promoter drives the reporter gene, Venus. The
ce (upper panels, (B)). Higher magniﬁcation of boxed regions in upper panels was
 24 h after MCAO (C). Scale bars = 20 m (B, upper panels, and C), 10 m (B, lower
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lides were examined with an Olympus confocal laser scanning
icroscope (FV-300, Olympus, Tokyo, Japan)..4. Generation of transgenic mice
4x RBP-J-binding sites, SV40 promoter and Venus were sub-
loned between the mouse H19 insulators of pWHERE (Invivogen,
ig. 2. Reporter gene expression was observed in the cortical peri-infarct region of the No
f  Venus (green), GFAP (red), Nestin (red), NG2 (red), Olig2 (red) and DAPI (blue) 24 h aftsearch 75 (2013) 204–209
SanDiego,  CA, USA). This Notch signaling reporter was  used to
generate Notch/RBP-J signaling reporter mouse line (RBRC03783)
by RIKEN Bioresource Center through the National Bio-resource
Project of the MEXT, Japan. This mouse line is maintained and
distributed by RIKEN Bioresource Center. All mice were maintained
in accordance with the Committee on Animal Research at Research
Institute, Shiga Medical Center.
tch signaling reporter transgenic mice after stroke. Immunohistochemical analysis
er MCAO. Scale bar = 10 m.
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Fig. 3. -Secretase inhibitor (DAPT) treatment reduced the proliferation of reactive
astrocytes  but not NG2-positive glial cells in the cortical peri-infarct area 3days after
stroke. (A, B, D, F) immunoﬂuorescence analysis for Nestin (green (A, D, F)), GFAP (red
(A), green (D)), RC2 (green (B)), NG2 (red (B)), BrdU (red (D and F)), active Caspase3
(red (D)) and DAPI staining of nuclei (blue (A, B, D)) 3 days after stroke. Confocal
images  of Nestin+, BrdU+ cells (bottom, orthogonal views). Scale bars = 50 m (A, D),
100 m (B). Single dose of BrdU (100 mg/kg) was administered 2 h before sacriﬁce.T. Marumo et al. / Neuroscie
. Results
.1. Notch signaling is activated in glial cells after
schemic-reperfusion
To characterize endogenous Notch/RBP-J signaling activation
fter stroke, we generated a transgenic Notch reporter line, which
xpress Venus under an artiﬁcial Notch/RBP-J-responsive promoter
ith four RBP-J binding sites and basal simian virus 40 (SV40) pro-
oter (Fujimoto et al., 2009; Mizutani et al., 2007) (Fig. 1A). A
enus is a GFP derivative with 10 fold strong ﬂuorescence than YFP
Nagai et al., 2002). We  ﬁrst conﬁrmed the reporter’s speciﬁcity
o Notch/RBP-J signal activation by examining Venus expression
n normal adult subventricular zone (SVZ) of Notch reporter mice.
s previously reported, Venus was expressed in GFAP-positive B
ells and Dlx2-positive C cells but not in PSA-NCAM-positive A
ells (Andreu-Agullo et al., 2009) (Fig. 1B) and this Venus expres-
ion was downregulated by a -secretase inhibitor (GSI), DAPT
N-[N-(3,5-diﬂuorophenacetyl-l-alanyl)]-S-phenyl-glycine t-butyl
ster) treatment (data not shown). The expression of Hes1, a well-
nown target of Notch signaling was observed in Venus-positive
ells (Fig. 1B). Next, to examine which type of glial cells show
otch activation in generation of reactive astrocytes, we performed
iddle cerebral artery occlusion (MCAO) in Notch reporter mice.
enus expression was enhanced in B cells and C cells in the SVZ
ith concomitant increased level of Hes1 expression 24 h after
CAO, as previously reported (Wang et al., 2009) (Fig. 1C). Ischemic
troke induced Venus expression both in peri-infarct and infarct
egions. Immunohistochemical analysis of peri-infarct area showed
hat Venus was expressed in 16.9 ± 2.3% of GFAP-positive cells,
5.3 ± 9.3% Nestin-positive cells and 23.3 ± 10.5% NG2-positive
ells 24 h after ischemia (Fig. 2).
.2. -Secretase inhibitor treatment decreased proliferation of
eactive  astrocyte but not NG2+ Cells
To examine whether Notch/RBP-J signaling is involved in glial
esponses after ischemia, we administrated DAPT 100 mg/kg s.c.
wice a day for 3 days after ischemia. GSI treatment drastically
educed the numbers of GFAP+ cells, Nestin+ cells and RC2+ cells
ut not NG2+ cells in the peri-infarct area (GFAP+ cells: DAPT,
.5 ± 0.3 × 10−3 cells/m2, DMSO, 2.1 ± 0.02 × 10−3 cells/m2,
 = 3, P = 0.049; Nestin+ cells: DAPT, 6.6 ± 2.2 × 10−4 cells/m2,
MSO, 1.2 ± 0.2 × 10−3 cells/m2, n = 3, P = 0.041; RC2+ cells: DAPT,
.5 ± 0.8 × 10−4 cells/m2, DMSO, 6.1 ± 1.2 × 10−4 cells/m2,
 = 3, P = 0.034; NG2+ cells: DAPT, 6.3 ± 1.4 × 10−4 cells/m2,
MSO, 5.3 ± 2.1 × 10−4 cells/m2, n = 3, P = 0.52 (Student’s t test))
Fig. 3A–C). Next, to get further insight into the mechanism of
educed number of reactive astrocytes, we performed bromod-
oxyuridine (BrdU) labeling experiments. BrdU was  administrated
nce 2 h before sacriﬁce 3 days after ischemia. The number of
rdU+ cells decreased in GFAP+ cells but not in Nestin+ cells (GFAP+
ells: DAPT, 9.5 ± 1.2 × 10−5 cells/m2, DMSO, 2.0 ± 0.6 × 10−4
ells/m2, n = 3, P = 0.046; Nestin+ cells: DAPT, 3.2 ± 3.1 × 10−5
ells/m2, DMSO, 5.3 ± 6.1 × 10−5 cells/m2, n = 3, P = 0.63 (Stu-
ent’s t test)) (Fig. 3D–F). Finally, we examined apoptotic cells 3
ays after stroke. Majority of active-Caspase3 positive apoptotic
ells existed in infarcted core regions and few were detected in the
eri-infarct area, which was not affected by GSI treatment (Fig. 3D).
hese ﬁndings suggest the GSI-induced reduced number of GFAP+
ells is caused by proliferation deﬁcits of GFAP+ cells.
.3.  -Secretase inhibitor treatment changed the localization of
lig2 in reactive astrocytes
Olig2  inhibits astrocyte differentiation from neural stem cells,
nd translocation of Olig2 from nucleus to cytoplasm promotes(C, E) Density of Nestin+, GFAP+, RC2+, NG2+ and BrdU+ cells in the cortical peri-
infarct  area. Values are the mean ± S.D. for 3 mice. *P = 0.041, **P = 0.049, ***P = 0.034
(C), *P = 0.046 (E) (Student’s t test).
astrocytic differentiation in vitro (Fukuda et al., 2004; Setoguchi
and Kondo, 2004). GSI prevents astrocyte differentiation of perina-
tal A2B5 glial progenitors by inhibiting cytoplasmic translocation
of Olig2 (Magnus et al., 2007). To determine whether GSI affects
radial glial proliferation through the regulation of Olig2 localiza-
tion in vivo, we examined Olig2 localization in reactive astrocytes
of 3-day GSI treated mice after ischemia. GSI treatment decreased
the number of GFAP+ nuclear-Olig2+ cells, GFAP+Olig2− cells and
Nestin+ nuclear-Olig2+ cells (GFAP+ nuclear-Olig2+ cells: DAPT,
1.9 ± 0.7 × 10−4 cells/m2, DMSO, 1.0 ± 0.2 × 10−3 cells/m2,
n = 3, P = 0.0057; GFAP+ Olig2− cells: DAPT, 2.8 ± 0.9 × 10−4
208 T. Marumo et al. / Neuroscience Research 75 (2013) 204–209
Fig. 4. -secretase inhibitor (DAPT) treatment changed the localization of Olig2 in reactive astrocytes in the peri-infarct area 3days after stroke. (A) Immunoﬂuorescence
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nnalysis  for GFAP (Green, upper panels), Nestin (green, lower panels), Olig2 (red) a
f Nestin+, GFAP+ cells with or without Olig2 in the peri-infarct area. Olig2 Nuc cells
eads). Values are the mean ± S.D. for 3 mice. *P = 0.0051, **P = 0.0057 (Student’s t t
ells/m2, DMSO, 9.5 ± 1.9 × 10−4 cells/m2, n = 3, P = 0.0051;
estin+ nuclear-Olig2+ cells: DAPT, 4.3 ± 1.8 × 10−5 cells/m2,
MSO, 1.6 ± 0.3 × 10−4 cells/m2, n = 3, P = 0.0055 (Student’s t
est)) (Fig. 4A and B). These observations indicated that GSI has an
pposite effect on Olig2 localization in reactive astrocyte differ-
ntiation in ischemic brains in vivo compared to that in astrocytic
ifferentiation in vitro.
.  Discussion
In this study, we showed that Notch/RBP-J signaling is activated
oth in NG2+ glial progenitors and reactive astrocytes in ischemic
rains. GSI treatment signiﬁcantly reduced proliferation and dif-
erentiation of GFAP+ reactive astrocytes, as previously reported
Shimada et al., 2011). The number of RC2+ and Nestin+ reactive
strocytes also decreased but not the number of NG2+ cells. It has
een reported that NG2+ cells provide a permissive environment
or regenerating axon, whereas reactive astrocytes produce chon-
roitin sulfate proteoglycans inhibitory to axonal growth (Busch
t al., 2010; Silver and Miller, 2004). These differential effects of GSI
n reactive astrocytes and NG2+ cells might be partially responsible
or its beneﬁcial effects on ischemic brain injury.
Reactive astrocytes are known to be composed of heteroge-
eous cell populations with distinct reactive astrocyte markerPI staining of nuclei (blue) 3 days after stroke. Scale bar = 25 m. (B and C) Density
2+ cells in the nucleus (arrows), Olig2Cyt cells: Olig2+ cells in the cytoplasm (arrow
), *P = 0.0055 (Student’s t test) (C).
expressions. The expressions of Nestin and RC2 are restricted to
peri-infarct region, whereas GFAP expression was found in astro-
cytes more distal to the infarct region (Zamanian et al., 2012).
Almost all RC2-positive astrocytes express Nestin after stroke
(Shimada et al., 2010). Nestin is induced 24 h after stroke and
returned to baseline 7 days after MCAO. In contrast, GFAP and
Vimentin expression are more persistently elevated (Zamanian
et al., 2012). The similar inhibitory effects of GSI on RC2-positive
and Nestin-positive cell proliferation are also consistent with these
ﬁndings.
Recent genetic fate mapping studies have shown majority of
reactive astrocytes generate from glutamate aspartate transporter
(GLAST)-positive quiescent astrocytes rather than NG2+ cells
(Buffo et al., 2008; Komitova et al., 2011). Majority of NG2+ cells
differentiate to mature oligodendrocytes even after brain injury
(Komitova et al., 2011). Furthermore, the analysis of cell-type
speciﬁc conditional knockout of Olig2 demonstrated that Olig2
expression in astrocytes but not in NG2+ cells is essential for
reactive astrocyte generation (Chen et al., 2008; Komitova et al.,
2011). All these ﬁnding and our data of differential effects of GSI
on reactive astrocytes and NG2+ cells might represent a lineage
difference between reactive astrocytes and NG2+ cells.
Our  data also showed that GSI treatment inhibits nuclear
translocation of Olig2 in reactive astrocytes. Previous reports
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emonstrated that nuclear Olig2 expression is observed in prolif-
rating reactive astrocytes (Chen et al., 2008). Olig2 localization
eﬁcits caused by GSI might be responsible for reduced prolif-
ration of reactive astrocytes. We  have previously shown that
otch/RBP-J signaling regulates expression level of Olig2 (Fujimoto
t al., 2009; Ikawa et al., 2006), which might affect the localization
f Olig2.
Notch signaling is known to play pivotal roles in astrocyte dif-
erentiation at multi-developmental stages. Notch/RBP-J signaling
romotes astrocytic differentiation from multipotent neural pre-
ursor cells (Ge et al., 2002; Tanigaki et al., 2001). Notch activation
nduced RBP-J-mediated transcriptional upregulation of nuclear
actor1, which demethylates astrocyte-speciﬁc-genes and enables
strocytic differentiation (Namihira et al., 2009). Adenovirus-
ediated and transgenic-mediated conditional knockout of RBP-J
ave demonstrated that RBP-J is indispensable for maintenance of
FAP astrocytes in adult SVZ, which are quiescent neural stem cells
Fujimoto et al., 2009; Imayoshi et al., 2010).
Taken together, our data have shown that GSI decreased
uclear-translocation of Olig2 and reduced the proliferation of
eactive astrocytes, but not affected NG2+ cells. These differen-
ial effects of GSI on glial development might partially explain its
herapeutic effects on ischemic injury.
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